{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:50:07Z","timestamp":1785858607370,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jcv.2015.11.005","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T04:45:17Z","timestamp":1446785117000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer"],"prefix":"10.1016","volume":"74","author":[{"given":"V.","family":"Senkomago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Des Marais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rahangdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.R.T.","family":"Vibat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Erlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2015.11.005_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1018435522475","article-title":"International incidence rates of invasive cervical cancer after introduction of cytological screening","volume":"8","author":"Gustafsson","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jcv.2015.11.005_bib0010","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1371\/journal.pmed.0050132","article-title":"Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities","volume":"5","author":"Gakidou","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.jcv.2015.11.005_bib0015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/jnci\/dji115","article-title":"Cervical cancer in women with comprehensive health care access: attributable factors in the screening process","volume":"97","author":"Leyden","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.11.005_bib0020","first-page":"1004","article-title":"Vital signs: cervical cancer incidence, mortality, and screening\u2014United States, 2007\u20132012","volume":"63","author":"Benard","year":"2014","journal-title":"MMWR Morb. Mortal Wkly Rep."},{"key":"10.1016\/j.jcv.2015.11.005_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10900-014-9948-1","article-title":"Human Papillomavirus Infection in women who submit self-collected vaginal swabs after internet recruitment","volume":"40","author":"Nelson","year":"2015","journal-title":"J. Community Health"},{"key":"10.1016\/j.jcv.2015.11.005_bib0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1701-2163(16)32636-6","article-title":"Self-collected samples for testing of oncogenic human papillomavirus: a systematic review","volume":"29","author":"Stewart","year":"2007","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.jcv.2015.11.005_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/CLEP.S39799","article-title":"Monitoring human papillomavirus prevalence in urine samples: a review","volume":"5","author":"Enerly","year":"2013","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.jcv.2015.11.005_bib0040","doi-asserted-by":"crossref","first-page":"g5264","DOI":"10.1136\/bmj.g5264","article-title":"Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis","volume":"349","author":"Pathak","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2015.11.005_bib0045","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10096-011-1358-z","article-title":"Detection of human papillomavirus DNA in urine: a review of the literature","volume":"31","author":"Vorsters","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.11.005_bib0050","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s10096-014-2147-2","article-title":"Optimization of HPV DNA detection in urine by improving collection, storage, and extraction","volume":"33","author":"Vorsters","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.11.005_bib0055","unstructured":"Trovagene HPV testing urine-based HPV test, Available at http:\/\/www.trovagene.com\/our-tests\/hpv\/ 2014; 2015."},{"key":"10.1016\/j.jcv.2015.11.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2014.04.016","article-title":"Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic","author":"Sahasrabuddhe","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.11.005_bib0065","unstructured":"Hologic Inc. APTIMA\/HPV Assay [Package Insert]. Bethseda, MD: Hologic Inc.; 2008."},{"key":"10.1016\/j.jcv.2015.11.005_bib0070","first-page":"255","article-title":"Median unbiased estimates","volume":"vol. 221","author":"Rothman","year":"2008"},{"key":"10.1016\/j.jcv.2015.11.005_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","author":"Huh","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.11.005_bib0080","doi-asserted-by":"crossref","first-page":"g6252","DOI":"10.1136\/bmj.g6252","article-title":"Urine testing for HPV: rationale for using first void","volume":"349","author":"Vorsters","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2015.11.005_bib0085","unstructured":"Centers for Disease Control. Laboratory Procudeure Manual. Analyte: Chlamydia trachomatis and Neisseria gonorrhoeae. Matrix: Urine. 2007; 2014, 30."},{"key":"10.1016\/j.jcv.2015.11.005_bib0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3346\/jkms.2007.22.1.99","article-title":"Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions","volume":"22","author":"Song","year":"2007","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.jcv.2015.11.005_bib0095","first-page":"513","article-title":"Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions","volume":"163","author":"Sellors","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.jcv.2015.11.005_bib0100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid\u2010based cytology in primary cervical cancer screening: The FASE study","volume":"129","author":"Monsonego","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.005_bib0105","first-page":"144","article-title":"APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results","volume":"208","author":"Stoler","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jcv.2015.11.005_bib0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ptj\/85.3.257","article-title":"The kappa statistic in reliability studies: use, interpretation, and sample size requirements","volume":"85","author":"Sim","year":"2005","journal-title":"Phys. Ther."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T01:21:35Z","timestamp":1599787295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653215007374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":22,"alternative-id":["S1386653215007374"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2015.11.005","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2015.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}